IP Library Granted Patent US 9,526,789
Granted Patent B2
US 9,526,789 · App. 14/369,640 · Granted Dec 27, 2016

Highly robust fast-disintegrating tablet and process for manufacturing the same

Inventors: Sang Yeob Park (Daejeon, KR); Hye Jung Lim (Daejeon, KR)
Assignee: SAMYANG BIOPHARMACEUTICALS CORPORATION
A61K47/26A61K9/1694A61K9/2018A61K9/2054A61K9/2059A61K9/2095A61K31/351A61K31/366A61K31/4178A61K31/4545A61K47/10A61K9/0056A61K9/1623
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,526,789
App. No.
14/369,640
Granted
Dec 27, 2016
Kind
B2
Abstract

Disclosed are an oral formulation which disintegrates quickly in the oral cavity; a fast-disintegrating tablet having fast disintegrability and high hardness, and a process for manufacturing the same. In addition, slightly wetted granules for manufacturing said fast-disintegrating tablet and a process for manufacturing the same are disclosed.

Claims (26)

1. A fast-disintegrating tablet, comprising slightly wetted granules that comprise a spray-dried mannitol and a sucrose binder, and have 1.05- to 5-times greater loss-on-drying than sufficiently dried granules,

wherein the fast-disintegrating tablet has the following properties (1) to (4);

(1) hardness of 4.0 Kp or more;

(2) friability of 0.5% or less;

(3) disintegration time in water of 1 minute or less; and

(4) disintegration time in an oral cavity of 30 seconds or less.

2. The fast-disintegrating tablet according to claim 1 , wherein the slightly wetted granules further comprise a dry binder.

3. The fast-disintegrating tablet according to claim 2 , wherein the dry binder is selected from the group consisting of saccharide, sugar alcohol, starch, polysaccharide, cellulose derivative and a mixture thereof.

4. The fast-disintegrating tablet according to claim 1 , wherein the spray-dried mannitol is comprised in an amount of 20 to 98% by weight, based on 100% by weight of the slightly wetted granules.

5. The fast-disintegrating tablet according to claim 1 , wherein the sucrose binder is comprised in an amount of 1 to 50 parts by weight as a dried sucrose, based on 100 parts by weight of the spray-dried mannitol.

6. The fast-disintegrating tablet according to claim 2 , wherein the dry binder is comprised in an amount of 50 or lower parts by weight, based on 100 parts by weight of the spray-dried mannitol.

7. The fast-disintegrating tablet according to claim 1 , which further comprises an active ingredient.

8. A process for manufacturing a fast-disintegrating tablet according to claim 1 , comprising the steps of:

forming granules comprising a spray-dried mannitol and a sucrose binder;

drying the granules to obtain slightly wetted granules having 1.05- to 5-times greater loss-on-drying value than sufficiently dried granules;

forming a post-granulation mixture for tableting comprising the slightly wetted granules;

compressing the post-granulation mixture under a pressure of 150 Mpa or less to obtain a tablet; and

drying the tablet.

9. The process for manufacturing the fast-disintegrating tablet according to claim 8 , wherein the sucrose binder is used in a dissolved state in water, non-aqueous solvent or a mixed solvent thereof.

10. The process for manufacturing the fast-disintegrating tablet according to claim 9 , wherein the concentration of sucrose is 1 to 60% (w/w), based on water, non-aqueous solvent or a mixed solvent thereof.

11. The fast-disintegrating tablet according to claim 1 , wherein the amount of slightly wetted granules is 50 to 99% by weight, based on 100% by weight of the tablet.

12. The process for manufacturing the fast-disintegrating tablet according to claim 8 , wherein the step of drying is conducted:

under the condition of temperature of 20 to 30° C. and relative humidity of 40% or less;

in a 20° C.- to 50° C.-convection oven;

by providing dry air; or

by using a dehumidifier or dehumidifying agent.

Assignments (3)
CHANGE OF ADDRESS Recorded Nov 3, 2021
From: SAMYANG BIOPHARMACEUTICALS CORPORATION
To: SAMYANG BIOPHARMACEUTICALS CORPORATION
Reel/Frame 058013/0696 →
MERGER Recorded Nov 3, 2021
From: SAMYANG BIOPHARMACEUTICALS CORPORATION
To: SAMYANG HOLDINGS CORPORATION
Reel/Frame 058013/0766 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2014
From: PARK, SANG YEOB; LIM, HYE JUNG
To: SAMYANG BIOPHARMACEUTICALS CORPORATION
Reel/Frame 033211/0826 →
Priority Claims (1)
KR 10-2011-0144395 · Dec 28, 2011 · national
Continuity (1)
Related Publication 20140364513A1 · Dec 11, 2014